New ILLUMENATE three-year Stellarex results announced at NCVH - Vascular News

New ILLUMENATE three-year Stellarex results announced at NCVH  Vascular News

The three-year safety and efficacy results for two trials using Philips' Stellarex, a sirolimus drug-coated balloon, were presented at NCVH.



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more